Home › Bladder Cancer › Illinois › Charleston
Bladder Cancer clinical trials in Charleston, IL
4 studies for Bladder Cancer are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingPhase 2
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
Other studies in Charleston
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Prostate Cancer7 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Melanoma4 studies
- Hypopharyngeal Cancer4 studies
- Endometrial Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.